Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$5.83−0.18 (-3.08%)
Close on Nov 18, 2026Market cap $108.99MP/E –Yield –
Trinity Biotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$37.38M. The highest annual figure on record is $21.80M in fiscal 2015.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$37.38M | – |
| FY2024 | Dec 31, 2024 | -$31.79M | – |
| FY2023 | Dec 31, 2023 | -$24.02M | – |
| FY2022 | Dec 31, 2022 | -$41.01M | -4786.7% |
| FY2021 | Dec 31, 2021 | $875.00K | – |
| FY2020 | Dec 31, 2020 | -$6.39M | – |
| FY2019 | Dec 31, 2019 | -$28.91M | – |
| FY2018 | Dec 31, 2018 | -$22.09M | – |
| FY2017 | Dec 31, 2017 | -$40.27M | – |
| FY2016 | Dec 31, 2016 | -$100.63M | -561.7% |
| FY2015 | Dec 31, 2015 | $21.80M | – |
See a number that looks wrong?